Literature DB >> 7549690

Treatment of acute anaphylaxis.

M Fisher1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7549690      PMCID： PMC2550723          DOI： 10.1136/bmj.311.7007.731

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  28 in total

1.  The impact of prednisone in life-threatening idiopathic anaphylaxis: reduction in acute episodes and medical costs.

Authors:  M B Boxer; P A Greenberger; R Patterson
Journal:  Ann Allergy       Date:  1989-03

2.  Demonstration of IgE-sensitized mast cells in human heart and kidney.

Authors:  E S Assem; N S Ghanem
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

3.  Second report from an anaesthetic reactions advisory service.

Authors:  J Watkins
Journal:  Anaesthesia       Date:  1989-02       Impact factor: 6.955

4.  Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment.

Authors:  E Søreide; T Buxrud; S Harboe
Journal:  Acta Anaesthesiol Scand       Date:  1988-05       Impact factor: 2.105

5.  Management of bee-sting anaphylaxis.

Authors:  S Gupta; J O'Donnell; A Kupa; R Heddle; G Skowronski; P Roberts-Thomson
Journal:  Med J Aust       Date:  1988 Dec 5-19       Impact factor: 7.738

Review 6.  Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention.

Authors:  M Fisher; B A Baldo
Journal:  Eur J Anaesthesiol       Date:  1994-07       Impact factor: 4.330

7.  External chest compression in acute asthma: a preliminary study.

Authors:  M M Fisher; C J Bowey; K Ladd-Hudson
Journal:  Crit Care Med       Date:  1989-07       Impact factor: 7.598

Review 8.  Impact of postoperative nausea and vomiting in the surgical setting.

Authors:  J Hirsch
Journal:  Anaesthesia       Date:  1994-01       Impact factor: 6.955

9.  Profound reversible myocardial depression after anaphylaxis.

Authors:  R F Raper; M M Fisher
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

10.  Biphasic systemic anaphylaxis: an inpatient and outpatient study.

Authors:  D M Douglas; E Sukenick; W P Andrade; J S Brown
Journal:  J Allergy Clin Immunol       Date:  1994-06       Impact factor: 10.793
View more
  20 in total

Review 1.  Antivenom therapy in the Americas.

Authors:  K Heard; G F O'Malley; R C Dart
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

Review 2.  Allergic emergencies in the emergency room.

Authors:  F Staikowsky; C Zanker; L Casenove
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 3.  Adrenaline in the treatment of anaphylaxis: what is the evidence?

Authors:  Andrew P C McLean-Tooke; Claire A Bethune; Ann C Fay; Gavin P Spickett
Journal:  BMJ       Date:  2003-12-06

4.  Blood cells and endothelial barrier function.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Tissue Barriers       Date:  2015-04-03

5.  "Not so immediate" hypersensitivity--the danger of biphasic anaphylactic reactions.

Authors:  E Brazil; A F MacNamara
Journal:  J Accid Emerg Med       Date:  1998-07

Review 6.  Therapeutic controversies in the management of acute anaphylaxis.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1998-03

7.  Treatment of acute anaphylaxis. Letters contained errors of logic.

Authors:  M Fisher
Journal:  BMJ       Date:  1996-03-09

8.  Treatment of acute anaphylaxis. Treatment takes precedence over monitoring.

Authors:  J Clear; M Yeoh; S Cockroft
Journal:  BMJ       Date:  1995-11-25

9.  Treatment of acute anaphylaxis. Surviving the journey is a good prognostic indicator.

Authors:  L C Luke
Journal:  BMJ       Date:  1995-11-25

10.  Treatment of acute anaphylaxis. Expressing the dose of adrenaline in milligrams is easier.

Authors:  S Campbell
Journal:  BMJ       Date:  1995-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.